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Volume 59, Number 6S Abstracts 11Sand more downward angulated renals were associated with
longer times for f-EVAR (31.4 vs 15.7 minutes, P ¼ .05).
The quartile of patients with the longest renal catheteriza-
tion times was associated with increased operative time
(303 vs 214 minutes, P < .001), ﬂuoroscopy time (125
vs 84 minutes, P ¼ .01), and blood loss (767 vs 473 mL,
P ¼ .01) in the f-EVAR cohort, and increased ﬂuoroscopy
time (86 vs 69 minutes, P ¼ .05) in the sn-EVAR group.
Conclusions: Preoperative RAA directly impacts the
time to renal catheterization and sheath placement, which
is the key step in f-EVAR and sn-EVAR. Angles steeper
than e30 favor the snorkel approach, whereas less angu-
lated renal arteries favor the fenestrated strategy. Further-
more, renal artery catheterization time is related to
procedural metrics of efﬁciency during complex EVAR;
therefore, operative strategies and device/technique selec-
tion should take into account signiﬁcant variations in renal
artery angulation.
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Objectives: Readmissions after complex vascular sur-
gery are not well studied. We hypothesized that the rate
of readmission after thoracic and thoracoabdominal aortic
aneurysm repair (TAA/TAAAR) is underestimated by
our single-center results and sought to analyze the risk fac-
tors and costs of these readmissions.
Methods: Using our institutional database in conjunc-
tion with Maryland Health Services Cost Review Commis-
sion, we reviewed index admissions and all statewide
readmissions of Maryland patients who underwent TAA/
TAAAR between 2002 and 2013 at Johns Hopkins Hospi-
tal (JHH).
Results: We identiﬁed 115 Maryland residents (mean
age, 65 6 1.2 years; 58% men; 57% open repair). Read-
missions occurred in 29% of cases. Most readmitted pa-
tients (79%; P < .001) were not readmitted to the
index hospital where their procedure was performed.
Readmitted patients were not signiﬁcantly different
from nonreadmitted patients in preoperative comorbid-
ities, aneurysm extent, or postoperative neurologic, renal,
or cardiovascular complications. On multivariate analysis,
signiﬁcant risk factors for readmission were open repair
(odds ratio, 3.1; P ¼ .03) and postoperative pneumonia
(odds ratio, 4.3; P ¼ .02). Striking differences were
seen between patients readmitted to JHH (R-JHH) vs
an outside hospital (R-OSH): R-JHH were readmitted
mainly for aneurysm-related surgical issues, and R-OSH
for medical morbidities. Seventy-ﬁve percent of R-JHH
required aneurysm-related intervention vs 9% of R-
OSH. R-OSH also had signiﬁcantly higher total index
hospitalization charges ($100,729 6 $12,772 vs
$43,225 6 $24,615, P ¼ .05).Conclusions: Readmissions after TAA/TAAAR are
frequent and occur at hospitals other than the index insti-
tution in the majority of cases. Risk factors for readmis-
sion include open repair and postoperative pneumonia,
but not pre-existing patient comorbidities. Our study
suggests preoperative assessment of patients for targeted
interventions to reduce readmission is not likely to be efﬁ-
cacious. Minimizing nonoperative complications may
reduce readmissions and the high costs associated with
repeat care.
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Objectives: Arteriovenous ﬁstula (AVF) is associated
with improved long-term outcomes but longer matura-
tion periods than arteriovenous graft (AVG). The Fistula
First Breakthrough Initiative has recently emphasized
tunneled dialysis catheter (TDC) avoidance. We sought
to characterize the relationship of AVF and AVG
to the utilization of TDCs as well as secondary proce-
dures, deﬁned as surgical revision, ﬁstulogram, and
thrombectomy.
Methods: Using the US Renal Data System (USRDS)
database, we identiﬁed incident hemodialysis (HD) pa-
tients in 2005 who started HD with a TDC and survived
at least 1 year. Access creation, TDC placement and sec-
ondary procedures were identiﬁed by Current Procedural
Terminology codes. Multivariate logistic regression was
used to identify risk factors for TDC placement or second-
ary procedures.
Results: In 2005, 56,839 patients started HD, 73%
with a TDC. Of those patients, 6286 had an access proce-
dure #3 months and had at least 1 year of follow-up avail-
able (AVF, 4,634; AVG, 1,652). Mean age was 67.7 years
(AVF, 67.4; AVG, 68.7; P < .001), 53.3% were male
(AVF, 57.9%; AVG, 40.5%; P < .001), and 33.9% were
obese (AVF, 33.6%; AVG, 34.6%; P ¼ NS). Multivariate
logistic regression demonstrates that AVG is associated
with more secondary procedures (odds ratio, 1.403; P <
.001) but signiﬁcantly lower TDC use (odds ratio, 0.845;
P ¼ .006). Lower body mass index, white race, older
age, and male gender also protect against TDC placement
(Table). Lower body mass index, male gender, white race,
and younger age are protective against secondary
procedures.
Conclusions: In patients starting HD with TDC,
AVG is associated with increased secondary procedures
but lower TDC placement at 1 year.
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(TDC) placement and secondary procedures
TDC placement Secondary proceduresPredictor OR P OR PArteriovenous graft 0.845 .006 1.403 <.001
Age (per decade) 0.949 .020 1.057 .014
White race 0.864 .012 0.731 <.001
Male gender 0.0831 .001 0.945 .298
BMI (per 5 units) 1.046 .015 1.06 .002BMI, Body mass index; OR, odds ratio.
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Objectives: The Agency for Healthcare Research and
Quality (AHRQ) Inpatient Quality Indicator (IQI) #11,
abdominal aortic aneurysm (AAA) repair inpatient mortal-
ity rate, is a measure of hospital quality, which is publically
reported but has not been externally validated. Because the
measure includes both intact and ruptured aneurysms and
open and endovascular repair, we hypothesized that IQI
#11 does not provide accurate assessment of mortality
risk after AAA repair.
Methods: Using AHRQ IQI software version 4.2, we
calculated observed (O) and expected (E) mortality rates
for IQI #11 for all hospitals performing AAA repair in
the Nationwide Inpatient Sample 2007-2011. We assessed
the correlation between expected rates as determined by
IQI #11 risk-adjustment methodology and observed rates
for all AAA repairs and in four cohorts stratiﬁed by aneu-
rysm stability (ruptured vs intact) and method of repair
(open vs endovascular).
Results: Among 187,773 AAA repairs performed at
1,268 United States hospitals, hospitals’ IQI #11 expected
rates correlated poorly with their observed rates (E: 5.0%6
4.4% vs O: 6.0% 6 9.8%; r ¼ 0.49). For ruptured AAA,
IQI #11 methodology underestimated the mortality risk
of open repair (E: 34% 6 7.2% vs 0: 40.1% 6 38.2%; r ¼
0.20) and endovascular repair (E: 24.8% 6 9% vs 0:
27.3% 6 37.9%; r ¼ 0.08). For intact AAA repair, IQI #11
methodology underestimated the mortality risk of open
repair (E: 4.3% 6 2.4% vs O: 6.3% 6 16.1%; r ¼ 0.24)but overestimated the mortality risk of endovascular repair
(E: 1.3% 6 0.8% vs O: 1.1% 6 3.7%; r ¼ 0.25). Hospitals’
observed mortality rates after intact AAA repair were not
correlated with their mortality rates after ruptured AAA
repair (r ¼ 0.03).
Conclusions: IQI #11 fails to provide an accurate
assessment of inpatient mortality risk after AAA repair.
Our results suggest that due to its poor validity, it is prema-
ture to use IQI #11 for quality reporting. Separate quality
measures that assess mortality risk after repair of ruptured
and intact AAAs, stratiﬁed by the use of open or endovas-
cular repair, should be developed.
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Objectives: The goal of carotid endarterectomy
(CEA) and carotid stenting (CAS) is to limit future stroke
during a patient’s lifetime. We linked data from the
Vascular Quality Initiative (VQI) with Medicare claims to
compare long-term stroke rate and 5-year stroke-free sur-
vival after CEA and CAS.
Methods: We linked 6,188 unique patients who
underwent primary CEA or CAS in VQI (2005-
2011) to their Medicare claims. We used VQI for peri-
operative and 1-year data and added long-term follow-
up from Medicare for stroke or death. We compared
the 5-year freedom from stroke and stroke or death
in crude and inverse propensity-weighted (IPW)
cohorts.
Results: Patients selected for CEA (n ¼ 5,792) or
CAS (n ¼ 396) were similar in age (73 years), and 56%
were asymptomatic in both groups. However, patients
selected for CAS were more likely to have diabetes, cor-
onary disease, congestive heart failure, and renal insufﬁ-
ciency. In-hospital stroke rate was similar for CEA and
CAS, in asymptomatic (1.5% vs 2.2%, P ¼ .34) and symp-
tomatic (2.3% vs 3.5%, P ¼ .29) patients. However, the
incidence of any stroke at 3 years was signiﬁcantly higher
after CAS compared with CEA (23% vs 13%, log-rank
P < .001; Fig). Further, failure to achieve 5-year
stroke-free survival was worse for CAS patients, both
asymptomatic (adjusted hazard ratio, 1.9; 95% conﬁ-
dence interval, 1.5-2.6; P < .001) and symptomatic
(adjusted hazard ratio, 1.6; 95% conﬁdence interval,
1.3-2.0; P < .001).
Conclusions: Patients selected for CAS in VQI have
worse long-term stroke rate and stroke-free survival
compared with patients treated with CEA, even when
